Abstract Mutations and chromosomal translocations occur in leukemic cells that result in elevated expression or constitutive activation of various growth factor receptors and downstream kinases. The Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways are often activated by mutations in upstream genes. The Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways are regulated by upstream Ras that is frequently mutated in human cancer. Recently, it has been observed that the FLT-3 and Jak kinases and the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) phosphatase are also frequently mutated or their expression is altered in certain hematopoietic neoplasms. Many of the events elicited by the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways have direct effects on survival pathways. Aberrant regulation of the survival pathways can contribute to uncontrolled cell growth and lead to leukemia. In this review, we describe the Raf/MEK/ ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT signaling cascades and summarize recent data regarding the regulation and mutation status of these pathways and their involvement in leukemia. Leukemia (2008) 22, 686–707; doi:10.1038/leu.2008.26; published online 13 March 2008 Keywords: Raf; PI3K; Akt; signal transduction; inhibitors;

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia / Steelman, Ls; Abrams, Sl; Whelan, J; Bertrand, Fe; Ludwig, De; Bäsecke, J; Libra, M; Stivala, F; Milella, M; Tafuri, A; Lunghi, P; Bonati, Antonio; Martelli, Am; Mccubrey, Ja. - In: LEUKEMIA. - ISSN 0887-6924. - 22:(2008), pp. 686-707. [10.1038/leu.2008.26]

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia

LUNGHI P;BONATI, Antonio;
2008-01-01

Abstract

Abstract Mutations and chromosomal translocations occur in leukemic cells that result in elevated expression or constitutive activation of various growth factor receptors and downstream kinases. The Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways are often activated by mutations in upstream genes. The Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways are regulated by upstream Ras that is frequently mutated in human cancer. Recently, it has been observed that the FLT-3 and Jak kinases and the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) phosphatase are also frequently mutated or their expression is altered in certain hematopoietic neoplasms. Many of the events elicited by the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways have direct effects on survival pathways. Aberrant regulation of the survival pathways can contribute to uncontrolled cell growth and lead to leukemia. In this review, we describe the Raf/MEK/ ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT signaling cascades and summarize recent data regarding the regulation and mutation status of these pathways and their involvement in leukemia. Leukemia (2008) 22, 686–707; doi:10.1038/leu.2008.26; published online 13 March 2008 Keywords: Raf; PI3K; Akt; signal transduction; inhibitors;
2008
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia / Steelman, Ls; Abrams, Sl; Whelan, J; Bertrand, Fe; Ludwig, De; Bäsecke, J; Libra, M; Stivala, F; Milella, M; Tafuri, A; Lunghi, P; Bonati, Antonio; Martelli, Am; Mccubrey, Ja. - In: LEUKEMIA. - ISSN 0887-6924. - 22:(2008), pp. 686-707. [10.1038/leu.2008.26]
File in questo prodotto:
File Dimensione Formato  
leukemia rev 2.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 588.48 kB
Formato Adobe PDF
588.48 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/1895290
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 329
  • ???jsp.display-item.citation.isi??? 301
social impact